Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination

Journal of Clinical Microbiology

Volumn 38, Issue 6, 2000, Pages 2210-2214

  Gerken, G ^a   Rothaar, T ^a   Rumi, M G ^b   Soffredini, R ^b   Trippler, M ^a   Blunk, M J ^c   Butcher, A ^c   Soviero, S ^c   Colucci, G ^d,e  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c HOFFMANN LA ROCHE INC   (United States)

^d Roche Molecular Diagnostics Ltd   (Switzerland)

^e Tegimenta AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS LOAD;

HEPATITIS C VIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0034082547     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.6.2210-2214.2000     Document Type: Article

References (30)

1. Albadalejo, J., R. Alonso, R. Antinozzi, M. Bugard, A.-M. Bourgault, G. Colucci, T. Fenner, H. Petersen, E. Sala, J. Vincelette, and C. Young. 1998. Multicenter evaluation of COBAS AMPLICOR HCV, an integrated PCR system for the rapid detection of hepatitis C virus RNA in the diagnostic laboratory. J. Clin. Microbiol. 36:862-865.
2. Bonino, F., M. R. Brunetto, F. Negro, M. Baldi, G. Saracco, M. L. Abate, A. Fabiano, and G. Verme. 1993. Hepatitis C virus infection and disease. Diagnostic problems. J. Hepatol. 17(Suppl. 3):S78-S82.
3. Calucci, G., and K. Gutekunst. 1947. Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C. J. Viral Hepatitis 4(Suppl. 1):75-78.
4. Conry-Cantilena, C. 1997. Hepatitis C virus diagnostics: technology, clinical applications and impacts. Trends Biotechnol. 15:71-76.
5. Damen, M., H. T. M. Cuypers, H. W. Zaaijer, H. W. Reesink, W. P. Schaasberg, W. H. Gerlich, H. G. M. Niesters, and P. N. Lelie. 1996. International collaborative study on the second EUROHEP HCV-RNA reference panel. J. Virol. Methods 58:175-185.
6. DiDomenico, N., H. Link, R. Knobel, T. Caratsch, W. Weschler, Z. G. Loewy, and M. Rosenstraus. 1996. COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine PCR. Clin. Chem. 42:1915-1923.
7. Dusheiko, G. M., S. Khakoo, P. Soni, and L. Grellier. 1996. A rational approach to the management of hepatitis C infection. Br. Med. J. 312:357-364.
8. Flichman, D., P. Colombatto, A. Randone, M. Baldi, G. Bellati, F. Negro, F. Oliveri, G. Colucci, G. Verme, F. Bonino, and M. R. Brunetto. 1997. Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study. Clin. Diagn. Virol. 8:63-70.
9. Gerken, G., P. Pontisso, M. Roggendorf, M. G. Rumi, P. Simmonds, C. Trepo, S. Zeuzem, and G. Colucci. 1996. Clinical evaluation of a single reaction, diagnostic PCR assay for the detection of hepatitis C virus (HCV) RNA. J. Hepatol. 24:33-37.
10. Gerken, G., P. Knolle, S. Jacobs, and K. H. Meyer Zum Buschenfelde. 1997. Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment. Arch. Virol. 142:459-464.
11. Gerken, G., and P. Knolle. 1997. Molecular analysis of hepatitis C virus, p. 167-181. In T. J. Harrison and A. J. J Zuckerman (ed.), The molecular medicine of viral hepatitis. Wiley & Sons Ltd., London, United Kingdom.
12. Gretch, D. R. 1997. Diagnostic tests for hepatitis C. Hepatology 26:43S-47S.
13. Gretch, D. R., C. dela Rosa, R. L. Carithers, R. A. Willson, B. Williams, and L. Corey. 1995. Assessment of hepatitis C viremia using molecular amplification technologies: correlation and clinical implications. Ann. Intern. Med. 123:321-329.
14. Hawkins, A., F. Davidson, and P. Simmonds. 1997. Comparison of plasma virus load among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay version 1 and 2, Roche Monitor assay, and in-house limiting dilution method. J. Clin. Microbiol. 35:187-192.
15. Jungkind, D., S. DiRienzo, K. G. Beavis, and N. S. Silverman. 1996. Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management. J. Clin. Microbiol. 34:2778-2783.
16. Karino, Y., J. Toyota, M. Sugawara, K. Higashino, T. Sato, T. Ohmura, T. Suga, Y. Okuuchi, and T. Matsushima. 1997. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Am. J. Gastroenterol. 92:61-65.
17. Longo, M. C., M. S. Berninger, and H. L. Hartley. 1990. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93:125-128.
18. Magrin, S., A. Craxi, C. Fabiano, R. G. Simonetti, G. Florentino, L. Marino, O. Diquattro, V. Di Marco, O. Loiacono, R. Volpes, et al. 1994. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 2:273-276.
19. Myers, T. W., and D. H. Gelfand. 1991. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 30:7661-7566.
20. Ohno, T., and J. Y. N. Lau. 1996. The "gold standard," accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology 24: 1312-1315.
21. Pawlotsky, J. M. 1997. Measuring hepatitis C virus viremia in clinical samples: can we trust the assay? Hepatology 26:1-4.
22. Romeo, R., V. Thiers, F. Driss, P. Berthelot, B. Nalpas, and C. Brechot. 1993. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion 33:629-633.
23. Rosenstraus, M., Z. Wang, S. Y. Chang, D. DeBoneville, and S. P. Spadoro. 1997. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J. Clin. Microbiol. 36:191-197.
24. Shiratory, Y., N. Kato, O. Yokosuka, F. Imazeki, E. Hashimoto, N. Hayashi, A. Nakamura, M. Asada, H. Kuroda, N. Tanaka, et al. 1997. Predictor of efficacy of interferon therapy in chronic hepatitis C virus infection. Gastroenterology 113:558-566.
25. Shiratory, Y., N. Kato, O. Yokosuka, E. Hashimoto, N. Hayashi, A. Nakamura, M. Asada, H. Kuroda, H. Ohkubo, Y. Arakawa, et al. 1997. Quantitative assays for hepatitis C virus in serum as predictor of the long-term response to interferon. J. Hepatol. 27:437-444.
26. Tedeschi, V., and L. B. Seeff. 1995. Diagnostic tests for hepatitis C: where are we now? Ann. Intern. Med. 123:383-385.
27. Trabaud, M. A., F. Bailly, S. N. Si-Ahmed, P. Chevallier, M. Sepetjan, G. Colucci, and C. Trepo. 1997. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J. Med. Virol. 52:105-112.
28. Young, K. K. Y., J. J. Archer, O. Yokosuka, M. Omata, and R. M. Resnick. 1995. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J. Clin. Microbiol. 33:654-657.
29. Zaaijer, H. J., H. T. M. Cuypers, and H. W. Reesink. 1993. Reliability of HCV PCR results. Lancet 341:722-724.
30. Zeuzem, S., J.-H. Lee, A. Franke, B. Rüster, D. Prümmer, G. Herrmann, and W. K. Roth. 1998. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 27:1149-1156.